Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →
Photo Credit: Eli Lilly With hiring underway, a state training center targeting 2028 and first production planned for 2030, Lilly’s Richmond site sets the clock on one of the region’s most significant biomanufacturing workforce builds. Eli Lilly and Company’s groundbreaking in Goochland County, just west of Richmond, was largely framed around its headline figures: a […]
Read More →A contract chemistry lab on the North Carolina coast now belongs to one of India’s largest generic drugmakers. Hyderabad-based Aurobindo Pharma disclosed on October 2, 2026 that its wholly owned subsidiary Apitoria Pharma Private Limited had completed the acquisition of A1 Biochem Group’s contract research services business, bringing Wilmington’s A1 Biochem Labs LLC into the […]
Clinical ink, a Winston-Salem, North Carolina, company that builds electronic clinical outcome assessment (eCOA) and connected device technology for clinical trials, announced on October 19, 2026 that Ardan Equity and GI Partners have each put new equity into the business. The two firms will now share control of the company. Chief Executive Officer Jonathan Goldman, […]
SAS, the Cary, North Carolina, data and AI software company, and North Carolina State University announced on October 1, 2026 the SAS Think & Do Tank, a research partnership that embeds SAS’ data, AI and analytics expertise in interdisciplinary work at NC State’s College of Agriculture and Life Sciences. NC State Chancellor Kevin Howell unveiled […]
BioHealth Capital Region – Regional Life Sciences Roundup – October 23, 2026 Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a […]
Photo Credit: Eli Lilly With hiring underway, a state training center targeting 2028 and first production planned for 2030, Lilly’s Richmond site sets the clock on one of the region’s most significant biomanufacturing workforce builds. Eli Lilly and Company’s groundbreaking in Goochland County, just west of Richmond, was largely framed around its headline figures: a […]
Raleigh-based central laboratory company LabConnect has signed a memorandum of understanding (MOU) with GCCL, a South Korean clinical trial sample analysis lab, to work together on global studies that span North America and the Asia-Pacific region. The two companies signed the agreement on October 12 at GCCL’s headquarters and announced it the next day. The […]
Ascentage Pharma, a commercial-stage biopharmaceutical company developing cancer therapies, with U.S. operations in Rockville, Maryland, announced on October 20, 2026 that its Bcl-2 inhibitor lisaftoclax (APG-2575) has received Breakthrough Therapy Designation (BTD) from the Center for Drug Evaluation of China’s National Medical Products Administration (NMPA). The designation covers lisaftoclax in combination with acalabrutinib for adults […]
The U.S. Food and Drug Administration announced the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), an agency-wide effort to strengthen the science and regulatory approaches used to develop treatments and medical technologies for conditions affecting the brain and nervous system. Its first initiative, the Alzheimer’s Prevention Accelerator, will examine how clinical trials can […]
Brii Biosciences, a Hong Kong-listed biotechnology company with U.S. operations in Durham, North Carolina, announced on October 15, 2026 that it has launched BRiSC™ (Bispecific RNAi SilenCing), its in-house platform for discovering small interfering ribonucleic acid (siRNA) medicines. The company says the platform’s signature feature is a molecular design that lets one siRNA drug silence […]
